{
  "id": 14717062,
  "title": "Osivax pivots to combo approach after flu jab fails in Phase 2b",
  "url": "https://urgent.news/2026/10/15/osivax-pivots-to-combo-approach-after-flu-jab-fails-in-phase-2b",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-15T14:33:55.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/osivax-pivots-to-combo-approach-after-flu-jab-fails-in-phase-2b/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Osivax’s lead flu vaccine has flopped in a mid-stage trial. But the French biotech still holds out hope for the program, and plans to combine it with existing flu shots. The Phase 2b trial aimed ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}